Sanara MedTech (SMTI) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
2 Feb, 2026Opening remarks and agenda
Meeting called to order by the Executive Chairman, welcoming shareholders and outlining virtual meeting procedures.
Board members and meeting officers introduced, with roles clarified for the session.
Agenda included election of directors, amendment of Certificate of Formation, approval of Long-Term Incentive Plan, and ratification of auditors.
Board and executive committee updates
Eight current board members were introduced, with nominations for re-election presented.
Shareholder proposals
Proposals included electing eight directors, amending the Certificate of Formation, approving the 2024 Long-Term Incentive Plan, and ratifying the appointment of auditors.
Proposal to elect a director for a new board vacancy was withdrawn and not voted on.
Latest events from Sanara MedTech
- Pure-play surgical wound care focus, strong growth, and new product launches drive future outlook.SMTI
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Q2 2024 revenue up 28% to $20.2M; gross margin 90%; net loss $3.5M; THP launch in 2025.SMTI
Q2 20241 Feb 2026 - Record Q3 revenue and EBITDA growth, but higher costs led to a larger net loss.SMTI
Q3 202414 Jan 2026 - Record Q3 revenue and strong growth reflect expanding adoption of advanced wound care platforms.SMTI
Piper Sandler 36th Annual Healthcare Conference11 Jan 2026 - Strong Q2 growth, leadership transition, and a promising product pipeline set the stage for expansion.SMTI
Cantor Global Healthcare Conference 202531 Dec 2025 - Revenue up 33% to $86.7M in 2024, with Q4 growth and strategic investments despite higher losses.SMTI
Q4 20242 Dec 2025 - Virtual annual meeting to elect directors and ratify auditor, with strong governance oversight.SMTI
Proxy Filing1 Dec 2025 - Q2 2025 revenue up 28%, Sanara Surgical profitable, THP under strategic review.SMTI
Q2 202523 Nov 2025 - Q1 2025 revenue up 26% to $23.4M, margin and EBITDA gains, but net loss widens to $3.5M.SMTI
Q1 202521 Nov 2025